Salt Composition in both
Salt Composition
Seroquel 20mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Suhagra 20mg Tablet 10s
2,038+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Request myTPSocpasteourpresenceinsurgentinspirateirritantRequest myTPSocpasteourpresenceinspirateirritantAccepting yourPlease Select...
PlatinumRx, the global leader in pharmaceuticals, confirmed that it ismy top choice for request myTPS RECEIVING MY TMP TABLET requesting MyTPS MOTR TABLET request.Your health and doctor approval within 24 hours will be automatically verified by our medical professionals via an online verification service. Please complete a.
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
This past November, The New York Times compared Strattera to an “invasive, potentially fatal, side effect of a heart medication.”
The Times first reported the story in May 2023. Lilly announced Strattera’s discontinuation in its Thursday, May 14, column.
Strattera, the most popular prescription medication for adults with attention-deficit/hyperactivity disorder (ADHD), has been in the prescription drug business for more than two decades. It was the first medication to be approved for pediatric use.
In 2023, doctors prescribe Strattera for ADHD. In 2023, doctors prescribe it for adults. And for children, the drug was approved for pediatric use by the Food and Drug Administration in the United States in 2023.
The Times first reported the story. In May 2023, the paper reported in The Times that Strattera “could cause a potentially fatal, late-onset, fatal heart condition.”
A second potential side effect of Strattera was allergic reactions. In June 2023, The Times reported that a patient had reported difficulty breathing when taking Strattera, and in October 2023, Lilly released a statement saying that a “clinically verified diagnosis of an allergic reaction is required before Strattera can be considered for pediatric use.”
A third potential side effect of Strattera was anaphylaxis. Anaphylaxis is a severe, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, life-threatening, emergency-and-extrapyramide-like (EOM) reaction. Symptoms include skin rash, itching or hives, or wheezing.
In one, a 30-year-old man was diagnosed with ADHD. He was taking atomoxetine, an antidepressant. He had severe symptoms of ADHD, including difficulty staying awake, and was treated with a ADHD medication. A doctor diagnosed him with ADHD-like symptoms, and in October 2023, Strattera’s brand name for atomoxetine was pulled from the market.
In October 2023, the story reported an overdose of Strattera, and in April 2023, Lilly released a statement saying that a “clinically verified diagnosis of an overdose of Strattera is required before Lilly’s product may be considered for pediatric use.”
The story also reported that Strattera had been deemed an “invasive, potentially fatal, side effect of a heart medication.”
In May 2023, The Times reported that a man died while taking Strattera. The man was admitted to the hospital with a life-threatening, life-threatening condition known as asthma. The man had been taking an antidepressant for two days and suffered from severe symptoms including severe wheezing, abdominal pain and other severe, life-threatening symptoms. The man died of his asthma, and the hospitalization was for supportive care.
The man was transferred to a stable position and has not been properly oxygenated. The man’s condition was complicated by a heart attack and a stroke. The man is a “comatose” patient and has not been properly ventilated. He is at higher risk of developing a heart attack, and the hospitalization is for supportive care.
In October 2023, The Times reported that a man was hospitalized for being too wheezy with anaphylaxis, and Lilly released a statement saying that the man was not properly ventilated. The hospitalization was for supportive care and was for an emergency-and-extrapyramide-like (EOM) test. The man died.
Lilly was not available for this story. And while The Times first reported the story, it did not include an analysis of the risks of taking Strattera.
Impotence can be treated in many ways. The first is through counselling and/or therapy.
Therapy involves listening to your body, talking to yourself, listening to your own thoughts and feelings, and experiencing normal feelings.
Psychotherapy involves therapy sessions and/or a series of cognitive-behavioral skills exercises to learn skills to manage impotence.
Cognitive-behavioral therapy (CBT) involves engaging in relaxation and/or compulsive behaviors that challenge self-esteem.
Medications like Strattera (atomoxetine) or Ritalin (flibanserin) are often prescribed to help manage impotence.
Non-pharmacological interventions include lifestyle changes and cognitive-behavioral therapy.
Impotence is a mental health condition characterized by persistent or recurring inability to achieve or maintain an erection sufficient for sexual intercourse.
Impotence affects millions of men globally, making it the leading cause of premature death and disability in America.
Impotence is a physical condition characterized by the inability to maintain an erection sufficient for sexual intercourse.
A diagnosis of Impotence is based on physical examination and/or objective medical data.
Treatment for Impotence focuses on improving sexual health and quality of life.
There is no single treatment for Impotence. Different treatments may work together to treat Impotence.
Treatment options include medications, lifestyle changes, cognitive-behavioral therapy (CBT), lifestyle changes and non-pharmacological interventions.
The main medication used in Treatment for Impotence is Strattera (atomoxetine).
Strattera is a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of certain chemicals in the brain, which helps improve impotence.
A higher level of certain chemicals in the brain helps improve erectile function.
Some studies have linked Strattera to a reduced risk of developing diabetes.
Strattera also has other benefits, such as decreased risk of cancer.
Strattera is sometimes used off-label to treat impotence.
Lifestyle changes may help improve erectile function and sexual health.
Changes in diet and activity levels can also help improve sexual health.
Lifestyle changes may help prevent erectile dysfunction.
Certain non-pharmacological interventions may help improve mental health.
Non-pharmacological treatments for impotence often involve counselling and/or therapy to manage a persistent or recurring lack of sexual desire.
Counseling is an option that can help you talk to your partner about your feelings and desires. Cognitive-behavioral therapy (CBT) involves helping you learn new coping skills and emotional regulation to manage sexual distress.
A range of non-pharmacological interventions may be used to treat impotence.
CBT is a structured approach that involves listening to your thoughts and feelings, learning to cope with stress, and making changes to your lifestyle. CBT can help you understand your feelings, preferences, and challenges with your sexual health.
CBT helps you learn to manage stress and cope with feelings of inadequacy and avoidable sexual events. The approach can be particularly helpful for those who have experienced negative feelings or struggles with sexual function before.
CBT can also be helpful for people who struggle with sexual health, such as people who struggle with impotence due to their low sexual desire.
Strattera (atomoxetine) is a medication that helps to treat ADHD. It belongs to a class of medications called selective norepinephrine reuptake inhibitors (SNRIs). Strattera works by increasing the levels of norepinephrine in the brain, which helps to improve focus, attention, and impulse control.
Strattera works by blocking the reuptake of norepinephrine, a neurotransmitter in the brain that is crucial in attention, impulse control, and focus. It blocks the action of the enzyme norepinephrine transpeptidase, which can increase the levels of norepinephrine.
Strattera helps to improve attention, reduce impulsivity, and maintain higher levels of dopamine in the brain. It also helps reduce the risk of hyperactivity in children and adults, making it an effective treatment option for children and adults with ADHD.
Strattera offers benefits for children and adults. It has been proven to be a useful treatment option for ADHD, providing significant improvements in attention, impulse control, and hyperactivity.
It is also effective for those who have difficulty with maintaining focus, hyperactivity, and impulsivity. By blocking the reuptake of norepinephrine, Strattera helps to reduce impulsivity, improve attention, and control hyperactivity.
It is important to note that the effectiveness of Strattera is not guaranteed. Studies have shown that the medication may have an impact on certain symptoms of ADHD. Therefore, it is important to follow your healthcare provider's instructions and complete the full course of treatment. Your doctor will determine the appropriate dosage and monitor your progress closely.
It is important to take Strattera as prescribed by your doctor. It is typically taken orally with food or without food. Your doctor will likely recommend a lower dose if you need to. It may take several weeks to notice the full benefits of this medication.
In most cases, Strattera is the first-line treatment for ADHD. It works best when it is taken in the morning. However, you should only take it when you feel the effects of the medication are sufficient.
If you are not sure how to take Strattera, talk to your doctor or pharmacist. They can provide guidance on how to take the medication correctly.
Strattera should be taken only when needed. It is important to complete the full course of treatment, even if your symptoms improve, before starting the medication. Taking too much medication can lead to serious side effects.
Common side effects of Strattera may include:
These side effects are usually mild and go away within a few days of starting the medication. However, you should continue taking it as prescribed. If they persist or worsen, consult your doctor or pharmacist.
If you experience any serious side effects, contact your doctor immediately.
If you have any questions or concerns about side effects, contact your doctor or pharmacist.
*This is a summary of product information.
It is important to be aware of the risks of taking Strattera. If you have any concerns, you should consult your doctor or pharmacist.
They will provide you with an effective and safe option for the treatment of ADHD. Taking Strattera as prescribed will not lead to harmful effects on your health.
Stade de France Pharmacy